Filtered By:
Condition: Atrial Fibrillation
Management: Health Insurance
This page shows you your search results in order of relevance. This is page number 10.
Order by Relevance | Date
Total 264 results found since Jan 2013.
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients with Atrial Fibrillation and Valvular Heart Disease.
CONCLUSIONS: NOACs had a comparable risk of ischemic stroke and bleeding in patients with AF and VHD, and reduced the risk of venous thromboembolism, intracranial hemorrhage, and mortality, compared to warfarin. Therefore, NOAC is an effective and safe alternative to warfarin in these patients.
PMID: 33538623 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - February 6, 2021 Category: Research Tags: Curr Med Res Opin Source Type: research
Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation
ConclusionsFor patients whose HAS-BLED scores increased to ≥ 3, the continuation of OACs was associated with better clinical outcomes. An increased HAS-BLED score in anticoagulated AF patients may not be the only reason to withhold OACs, but reminds physicians to correct modifiable bleeding risk factors and follow up patients more closely.Graphical abstractAssociations between Continuation or Discontinuation of Oral Anticoagulants and Risks of Clinical Outcomes after HAS-BLED Scores IncreasedAF atrial fibrillation;aHR adjusted hazard ratio;ICH intra-cranial hemorrhage;OACs oral anticoagulants
Source: Clinical Research in Cardiology - March 11, 2021 Category: Cardiology Source Type: research
Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study
ConclusionsIn Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation, rivaroxaban may be associated with a similar risk of major bleeding but a lower risk of thromboembolism compared with warfarin. The potential benefit of 10 mg of rivaroxaban in this population requires further investigation.
Source: PLoS One - April 8, 2021 Category: Biomedical Science Authors: Yi-Cheng Lin Source Type: research
Cardiovascular disease and the risk of dementia: a survival analysis using administrative data from Manitoba
CONCLUSION: A diagnosis of CVD is associated with an increased risk of a future diagnosis of dementia. Promoting good cardiovascular health may serve as an effective measure for preventing dementia.PMID:35025100 | DOI:10.17269/s41997-021-00589-2
Source: Canadian Journal of Public Health - January 13, 2022 Category: International Medicine & Public Health Authors: Luc Clair Hope Anderson Christopher Anderson Okechukwu Ekuma Heather J Prior Source Type: research
Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation
ConclusionsFor patients whose HAS-BLED scores increased to ≥ 3, the continuation of OACs was associated with better clinical outcomes. An increased HAS-BLED score in anticoagulated AF patients may not be the only reason to withhold OACs, but reminds physicians to correct modifiable bleeding risk factors and follow up patients more closely.Graphical abstractAssociations between Continuation or Discontinuation of Oral Anticoagulants and Risks of Clinical Outcomes after HAS-BLED Scores IncreasedAF atrial fibrillation;aHR adjusted hazard ratio;ICH intra-cranial hemorrhage;OACs oral anticoagulants
Source: Clinical Research in Cardiology - January 1, 2022 Category: Cardiology Source Type: research
Cardiovascular disease and the risk of dementia: a survival analysis using administrative data from Manitoba
CONCLUSION: A diagnosis of CVD is associated with an increased risk of a future diagnosis of dementia. Promoting good cardiovascular health may serve as an effective measure for preventing dementia.PMID:35025100 | DOI:10.17269/s41997-021-00589-2
Source: Canadian Journal of Public Health - January 13, 2022 Category: International Medicine & Public Health Authors: Luc Clair Hope Anderson Christopher Anderson Okechukwu Ekuma Heather J Prior Source Type: research
A Retrospective Population-Based Survival Study of Idiopathic Pulmonary Arterial Hypertension in Korea
CONCLUSION: The 10-year SR of IPAH was 57% in Korea. The HR for IPAH was significantly high in patients with older age and other risk factors.PMID:35289139 | DOI:10.3346/jkms.2022.37.e80
Source: J Korean Med Sci - March 15, 2022 Category: General Medicine Authors: Shin Yi Jang Eun Kyoung Kim June Huh Jinyoung Song I-Seok Kang Seung Woo Park Duk-Kyung Kim Sung-A Chang Source Type: research
